Viewing Study NCT00195104


Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2026-02-23 @ 2:22 AM
Study NCT ID: NCT00195104
Status: COMPLETED
Last Update Posted: 2017-03-03
First Post: 2005-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML
Sponsor: Weill Medical College of Cornell University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 0603-887
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators